Gene · 55
Papers3,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases. | Diagn Pathol | 2021 | 33892760 | PubTator, text mining | PubMed |
| Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens. | Genes Cancer | 2021 | 33884106 | PubTator, text mining | PubMed |
| Turning cold tumors into hot tumors by improving T-cell infiltration. | Theranostics | 2021 | 33859752 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals the encystment-related lncRNA expression profile and coexpressed mRNAs in Pseudourostyla cristata. | Sci Rep | 2021 | 33859278 | PubTator, text mining | PubMed |
| mRNA therapeutics in cancer immunotherapy. | Mol Cancer | 2021 | 33858437 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the expression and role of microRNA-221-3p in head and neck squamous cell carcinoma. | BMC Cancer | 2021 | 33845800 | PubTator, text mining | PubMed |
| Mining the plasma-proteome associated genes in patients with gastro-esophageal cancers for biomarker discovery. | Sci Rep | 2021 | 33828156 | PubTator, text mining | PubMed |
| How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. | Prostate Cancer Prostatic Dis | 2021 | 33820953 | PubTator, text mining | PubMed |
| COL5A2 Promotes Proliferation and Invasion in Prostate Cancer and Is One of Seven Gleason-Related Genes That Predict Recurrence-Free Survival. | Front Oncol | 2021 | 33816226 | PubTator, text mining | PubMed |
| Urinary Extracellular Vesicles as Potential Biomarkers for Urologic Cancers: An Overview of Current Methods and Advances. | Cancers (Basel) | 2021 | 33810357 | PubTator, text mining | PubMed |
| The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy. | Pharmaceutics | 2021 | 33809779 | PubTator, text mining | PubMed |
| Nanoproteomic Approach for Isolation and Identification of Potential Biomarkers in Human Urine from Adults with Normal Weight, Overweight and Obesity. | Molecules | 2021 | 33806905 | PubTator, text mining | PubMed |
| Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy. | Cancers (Basel) | 2021 | 33806808 | PubTator, text mining | PubMed |
| Novel Strategies for Treating Castration-Resistant Prostate Cancer. | Biomedicines | 2021 | 33801751 | PubTator, text mining | PubMed |
| Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer. | Cancers (Basel) | 2021 | 33800156 | PubTator, text mining | PubMed |
| Negatively Charged Peptide Nanofibrils from Immunoglobulin Light Chain Sequester Viral Particles but Lack Cell-Binding and Viral Transduction-Enhancing Properties. | ACS Omega | 2021 | 33778283 | PubTator, text mining | PubMed |
| Discovery of New Protein Targets of BPA Analogs and Derivatives Associated with Noncommunicable Diseases: A Virtual High-Throughput Screening. | Environ Health Perspect | 2021 | 33769846 | PubTator, text mining | PubMed |
| Mining The Cancer Genome Atlas gene expression data for lineage markers in distinguishing bladder urothelial carcinoma and prostate adenocarcinoma. | Sci Rep | 2021 | 33762601 | PubTator, text mining | PubMed |
| Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer. | Sci Rep | 2021 | 33758314 | PubTator, text mining | PubMed |
| LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer. | Biomed Res Int | 2021 | 33728331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55/papers?page=29